3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Down Syndrome
3
Osteosarcoma
2
Lymphoma, Mantle-Cell
2
Urothelial Carcinoma of the Bladder
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Mouth Neoplasms
1
Meningeal Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
GATA2 Deficiency
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma
1
Interventions
durvalumab
2
Tretinoin
2
Paclitaxel
2
Carboplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Pemetrexed
1
MK 2206
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Methotrexate
×
30 days
×
Clear all
No trials found.